Green Digital Diabetes Waste Project

Sponsor

Florida State University (Other)

Overall Status

Recruiting

CT.gov ID

NCT06071325

Collaborator

Diabetes Technology Society (Other)

Enrollment

Locations

7.4

Anticipated Duration (Months)

Patients Per Site

2.7

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to determine how people with diabetes are disposing of various products and devices and at what rates so that better devices with less waste can be designed in the future.

Condition or Disease	Intervention/Treatment	Phase
Diabetes Mellitus Diabetes Mellitus, Type 2 Diabetes Mellitus, Type 1

Detailed Description

The study aims to compare the amount of environmental waste that is generated during the management of diabetes of participants who are using a CGM and on multiple daily injection (MDI) or using an AID (automated insulin delivery) system. This study is expected to demonstrate which devices create the most waste and where opportunities exist to decrease diabetes device waste. We will collect data to describe both quantitatively (via daily survey) and qualitatively (via photography) the types of waste that are generated during the management of diabetes.

Study Design

Study Type:

Observational

Anticipated Enrollment :

40 participants

Observational Model:

Cohort

Time Perspective:

Prospective

Official Title:

Green Digital Diabetes Waste Project: Quantifying the Amount of Environmental Waste Associated With Devices and Technology

Actual Study Start Date :

Sep 19, 2023

Anticipated Primary Completion Date :

Dec 31, 2023

Anticipated Study Completion Date :

Apr 30, 2024

Arms and Interventions

Arm	Intervention/Treatment
AID Group We anticipate enrolling between 30 and 50 participants who will be recruited to participate in the Automated Insulin Delivery (AID) system study.
MDI + CGM Group We anticipate that between 10 and 30 participants will be enrolled in the study and will be utilizing Multiple Daily Injections (MDI) therapy in conjunction with Continuous Glucose Monitoring (CGM). MDI therapy will be defined as administering three or more injections per day.

Outcome Measures

Primary Outcome Measures

Types and Amount of Diabetes Waste [30 days]
Types and Amount of Environmental Waste Related to Diabetes Management as Measured Quantitately by Survey and Qualitatively by Photos

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 120 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Person with diabetes (self-identified), either type 1 or type 2, who has been diagnosed at least 6 months earlier
Age 18 years and above
Use of a CGM
Use of an insulin pump or on MDI
Access to the Internet and e-mail
Access to a smartphone with photographic capability
Able and willing to provide informed consent

Exclusion Criteria:

Failure to meet any of the inclusion criteria
Any condition which, in the opinion of an investigator, would make the subject not qualified to participate in the study.
Adults unable to consent
Adults unable to speak English
Individuals who are not yet adults (infants, children, teenagers)
Pregnant women
Prisoners
Cognitively impaired adults

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Diabetes Technology Society	Burlingame	California	United States	94010
2	Florida State University	Tallahassee	Florida	United States	32306

Sponsors and Collaborators

Florida State University
Diabetes Technology Society

Investigators

Principal Investigator: Jing Wang, PhD, Dean & Prof. of FSU College of Nursing
Principal Investigator: David C Klonoff, MD, President of Diabetes Technology Society and Clinical Professor of UCSF Medicine